Company Filing History:
Years Active: 2018
Title: John Dicarlo: Innovator in Gene Expression and Signaling Pathways
Introduction
John Dicarlo is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of gene expression and signaling pathways, particularly through his innovative patent related to the IL-6/STAT3 signaling pathway. His work has implications for understanding and treating various diseases.
Latest Patents
John Dicarlo holds a patent titled "Gene expression signature for IL-6/STAT3 signaling pathway and use thereof." This invention relates to a set of biomarkers and microarrays that facilitate the detection of these biomarkers. The expression signature comprises 16 genes or a subset thereof, which can be used to determine the regulation status of the IL-6/STAT3 signaling pathway in a cell sample or subject. The methods and compositions provided in this patent can evaluate the regulation status of the IL-6/STAT3 pathway, classify cell samples, and predict responses to agents that modulate this pathway.
Career Highlights
Throughout his career, John Dicarlo has worked with prominent companies in the biotechnology sector, including Qiagen Sciences, LLC and Qiagen GmbH. His expertise in gene expression and signaling pathways has positioned him as a valuable asset in the field of biomedical research.
Collaborations
John Dicarlo has collaborated with notable professionals in his field, including Zhong Wu and Martin Schlumpberger. These collaborations have further enhanced his research and contributions to the scientific community.
Conclusion
John Dicarlo's innovative work in gene expression and signaling pathways has made a significant impact in the field of biotechnology. His patent on the IL-6/STAT3 signaling pathway exemplifies his commitment to advancing scientific knowledge and improving therapeutic strategies.